AVADEL PHARMACEUTICALS PLC — Director's Dealing 2017

Jan 13, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2017-01-03

Reporting Person: DIVIS GREG J (See Remarks)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$10.40	2026-12-14	ADSs (150000)		Direct

Footnotes

F1: Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.

F2: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.